Last reviewed · How we verify

89Zr-DFO-YS5

Robert Flavell, MD, PhD · Phase 1 active Small molecule

At a glance

Generic name89Zr-DFO-YS5
Also known asimmunoPET agent, Imaging Agent
SponsorRobert Flavell, MD, PhD
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: